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Abstract 
The Chronic Effects of Estradiol Benzoate on Ventricular Myocardial 
Blood Flow in the Adult Female Rat. 
Stephen Maurice Ashe 
Virginia Commonwealth University, 1980 
Major Director: Dr. Loren G. Martin 
Clinical and experimental data suggest that humans and some animals 
are protected from acute myocardial infarction by estrogen. There has 
been much speculation of the exact role which estrogen plays in the 
circulation. The mechanism of this hormonally related protection is 
unclear. 
In the present study the chronic effects of estradiol benzoate on 
coronary blood flow in adult female rats were studied. Female control 
rats, castrates and castrates receiving estrogen for a period of 16 
weeks were used. In vivo tracer microsphere studies of myocardial 
blood flow allowed the quantification of the effects of estrogen on 
coronary circulation. Results of this work demonstrated that levels of 
estrogen significantly influence blood flow in ventricular myocardium. 
Literature Review 
Perhaps the most general effect of estrogens (Figure 1) is to 
proliferate tissue growth by stimulating cell division (Turner and 
Bagnara, 1976). Much attention, however, has been focused on estrogen 
and its relationship to coronary atherosclerosis (Blumgart, 1968). 
Clinical and experimental evidence suggest that physiological levels 
of estrogens mitigate or postpone many circulatory ailments such as 
hypertension, coronary artery disease, myocardial ischemia and certain 
pathologic changes in the electrocardiogram (Stumpf et al., 1977). 
There is evidence that cardiovascular disease is more common 
in men than women in the United States. This data has been ascribed 
to both stress in males and the effects of protective hormones in females 
(Stumpf et al., 1977). Treatment with estrogen has been observed to 
strongly exert a beneficial effect of significantly prolonging survival 
and decreasing the mortality rate by 50% in men who have already 
experienced an acute myocardial infarction (Stamler et al., 1963). How 
estrogen exerts this effect is not lalown. Conversely, however, McCall 
et al. (1980) has contended that exogenous estrogen increased mortality 
in men with a pervious myocardial infarction. 
Rona et al. (1963) and Wexler (1969) have shown that the male rat 
is more susceptible than the female to the necrogenic actions of 
isoproterenol. Medically, isoproterenal is a 6-adrenergic stimulant 
2 
Figure 1. Representation of the molecular structure of Estradiol 17B. 
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that in small doses is a positive inotrope and a positive chronotrope; 
in large doses this drug produces cardiac toxicity (Melmon and Morrelli, 
1972). It was suggested that the increased susceptibility of the male 
rat may result from the fact that the male rat weighs more than the 
female at any given age (Rona et al., 1963). McGrath and Martin (1975) 
found that the female Japanese Quail, which consistently weighs more than 
the male, has a much greater resistance to myocardial necrotic agents. 
This finding disputes the weight-basis hypothesis. It also was 
demonstrated that the exogenous administration of estrogen can protect 
the male Japanese Quail from necrotic lesions of the heart induced by 
isoproterenol. The mechanism by which estrogen may exert its protective 
effect in this instance is unclear. 
Rigano et al. (1963)noted that estrogen had induced augmented 
resistance to cardiovascular disease after two-year estrogen replacement 
therapy in castrated human females. Oophorectomized women without this 
replacement therapy displayed accelerated artherosclerosis in the form 
of myocardial infarctions, peripheral vascular disease and cerebral 
thrombosis. 
The mechanisms by which estrogens exert their protective effects 
are not known and estrogens are new factors in coronary artery disease 
whose roles need to be defined (Lancet, 1977), It has been demonstrated 
that a decrease in uterine, renal and peripheral vascular resistance 
accompanies pregnancy and that this decrease in resistance can be 
duplicated by the experimental administration of estrogen (Sullivan, 
1974). Estrogen acting on smooth muscle of the blood vessels causes 
vasodilation in the uterine area. Estrogen also may play an important 
role as a relaxer of the umbilical cord artery favoring its relaxation 
(Silva De Sa' and Meirelles, 1977), Jaffe (1977) however has postulated 
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that estrogen induces an increase in smooth muscle tone of the coronary 
artery. Brown et al. (1974) has noted that peaks in uterine blood flow 
during the estrous cycle of the ewe coincide with cyclic surges of 
estrogen secretion, and that these blood flow changes can be reproduced 
experimentally by estrogen and progesterone administration. Thus 
estrogen has been shown to be a potent vasodialator in various vascular 
beds (Sullivan, 1974) and (Brown et al., 1974), but its specific action 
on myocardial blood flow has not been evaluated or described. 
Autoradiographic studies of the rat heart have revealed that 
estradiol concentrates in the cell nuclei of the myocardium of the 
atria and auricles, as well as the myometrium of the uterus. It has 
also been demonstrated, with studies utilizing ( 3H) estradiol, that 
estradiol has target sites in the walls of blood vessels in heart muscles 
(Stumpf et al., 1977), 
Although the physiological basis is not known, premenopausal women 
have a lower incidence of death from myocardial infarction than men 
(Stamler, 1967), but many investigators postulate that estrogen itself 
is unlikely to provide this protection. This assumption is supported by 
the findings that estrogen administration at contraceptive levels has 
been associated with an increase in incidence of both myocardial 
infarction (Robinson et al., 1963) and stroke (McDowell et al., 1967). 
The same associations have also been found for estrogen used in conjunction 
with progestogens at oral contraceptive levels for myocardial infarction 
(Waxler et al., 1971) and stroke (Horenstein, 1975), 
The results of some of these studies are strongly supportive of 
estrogen effecting the cardiovascular system. Though some of the 
studies support that estrogen does effect the incidence of myocardial 
infarction, most of the studies fail to explain why these results occur. 
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Many of the studies used contraceptive levels of estrogen (Jaffe, 1977; 
Robinson et al., 1963; Waxler et al., 1971). The studies did not 
evaluate how estrogen effects blood flow to the myocardium. There Ls 
a need for studies to be conducted using normal physiologic replacement 
levels of estrogen. There is also some inconsistant data on the 
vasodialating qualities of estrogen (Sullivan, 1974 and Brown et al., 
1974) as opposed to it increasing coronary artery smooth muscle tone 
(Jaffe, 1977). Further examination of the effects of high and low 
estrogen levels is needed (Lancet, 1977), This study may be able to 
resolve some of the questions raised from previous data. 
Materials and Methods 
Animals and Hormonal Treatment 
One month old, CD Strain, female rats (Charles River Breeding Labs.) 
were maintained on Purina Rat Chow and tap water ad libitum. All 
animals were housed in the laboratory at 70 ± 2
°
F with a fluorescent 
lighting schedule of 12 L: 12 D. 
Hormonal and Surgical Treatment 
Estradiol benzoate (Sigma Chemical Co.) was dissolved in cottonseed 
oil (Eastman Kodak Co.) and administered daily as 0.1 ml intraperitoneal 
(i.p.) injections for a period of 16 weeks as in Table 1. 
The estradiol replacement hormone levels in this research were 
selected as a result of the studies of McPherson et al. (1974) and 
Eldridge et al. (1974). These researchers, utilizing castrate animals, 
based their "normal" replacement levels on both bioassay replacement 
weights of accessory sex glands and radioimmunoassay suppression studies 
of pituitary gonadotrophins using daily exogenous injections of estradiol 
benzoate. 
Demonstration of Coronary Blood Flow 
A. The cannulation of the left femoral artery 
The rats were anesthetized with 5 mg/100 gms of sodium phenobarbital 
Table 1. 
Group 
1 
2 
3 
4 
Surgical and Hormonal Treatment of the Four Treatment 
Groups. 
Surgical Daily Hormonal 
Gender (n) Treatment Treatment 
Female (10) ovariectomized Oil 
(0.1 ml) 
Female (10) None None 
Female (10) ovariectomized 4.0 µg estradiol 
benzoate in oil 
(0.1 ml) 
Female (10) ovariectomized 40.0 µg estradiol 
benzoate in oil 
(0.1 ml) 
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administered intraperitoneally (i,p.) and the left femoral artery was 
then cannulated. A longitudinal cut of approximately two inches was 
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made between the abdomen and the left leg to expose the femoral artery. 
A branch of the femoral artery, the deep femoral artery, was clamped and 
cut to make it easier to manipulate the femor�l artery. Next, connective 
tissue was cleared away until the femoral artery became clearly visible. 
The artery was mobilized by loosening it from concommitant neural 
tissue. Forceps were used to elevate the artery to free it from the 
vein until about 0.6 cm of artery was free. Suture string and hemostats 
were used to loosely ligate the artery. The sutures were looped around 
the artery, pulled and then clamped with hemostats to supply the proper 
tension. This was done to both the proximal and distal ends of the 
artery in order to elevate the artery, making it clearly visible and 
easier to reach. In addition, the increase in local resistance slowed 
blood flow into this region of the artery. Iris scissors were used to 
make a small angular cut at the distal end of the elevated artery. 
At this point the artery was again checked for any excess connective 
tissue since its presence would hamper the insertion of the tube. When 
blood began to seep from the cut in the artery, the points of the 
scissors were inserted into the artery and reciprocated in and out 
several times in order to make the incision clear and visible. Next, 
while holding tight the distal suture with the wrist to prevent the artery 
from moving, the beveled end of PE 50 tubing (Clay Adams, Parsippany, 
N.J.), cut to approximately two and one half feet and filled with 
heparinized saline, was inserted into the artery. Pressure was still 
being placed on the proximal end to prevent loss of blood. After the 
tube was situated, it was inserted further and more securely into the 
artery by using a forcep on the tube in the artery and a forcep on the 
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tube outside the artery. Once in place, the tube was securely tied into 
the artery. A syringe withdrawal pump (Harvard apparatus, Millis, Mass.) 
connected to the tube was then started for a few seconds to withdraw 
a minimal amount of blood. The tube was then observed to ascertain the 
presence of a pulse. This insured a clear and unobstructed flow during 
the reference sample withdrawal period. 
B. Microsphere injection 
Styrene-divinyl benzene copolymer microspheres (15 ± 3 µm diameter, 
density approximately 1.38/cc, (New England Nuclear, Boston, Mass.) 
labeled with cobalt-57 were used. They are non-biodegradable and 
essentially no activity can be leached form the labeled spheres (0.15% 
leach in 5 ml saline after 15 days at room temperature; a sample giving 
100,000 CPMs gives less than 2.5% leach in plasma after 48 hours at 
38°c). The microspheres also will not aggregate. The size and density 
chosen was that which was as close to the diameter (7-8 µm) and 
density (l.Ol/cm3) of normal red blood cells as possible. Thus the 
microspheres should circulate as normal blood cells through body tissue 
until they became trapped in the microvasculature. The microspheres 
were drawn into a 1 ml disposable tuberculin syringe (Raku.san and 
Blahitka, 1974). After the bottle had been agitated by vortex for 30 
seconds to suspend all the microspheres equally in the solution, a 
bolus of 0.05 ml was withdrawn from the stock solution. The bolus 
contained approximately 100,000 microspheres. 
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C. Cardiac Puncture 
The microspheres were injected via cardiac puncture (Rakusan and 
Blahitka, 1974) using a 2.5 cm, 23 gauge needle. "Penetration was 
made with the needle in an area on the left side of the closed thorax 
between the fifth and sixth ribs in an area slightly to the left and 
above the region where the xyphoid process joins the main body of the 
sternum" (Rakusan and Blahitka, 1974). To make sure the needle was 
located properly inside the left ventricle, a small amount of blood 
was withdrawn and then the microspheres were quickly injected. The 
withdrawal pump was started immediately before the cardiac puncture 
and remained on for 120 seconds after the injection. A withdrawal 
rate of 0.0383 ml/min was used to withdraw blood from the femoral 
artery with a 2.0 ml silicone-treated glass syringe. After this 
reference sample was obtained, the animals were sacrificed and the 
heart removed. 
D. Ventricle procurement 
The atria were excised and discarded. The right ventricle was 
then separated from the left ventricle and septum by pinning the heart 
to a block of wax and carefully pulling and cutting the right ventricle 
from the septum (Martin et al., 1972). The left ventricle was then 
cut from the anterior end to the apex and opened (Figure 2). Both the 
right and left ventricles were dipped twice in 50 ml of saline solution 
and blotted twice on filter paper to remove any residual blood or 
microspheres not lodged in ventricular microvasculature. The ventricles 
were then weighed on a Mettler balance (Model PC 4400). The kidneys 
were also removed and weighed to demonstrate equal bilateral microsphere 
distribution. The ventricles, kidneys.and PE tubing containing the 
reference sample were placed in vials and counted by a Beckman Gamma 
Counter (Model 8000). 
E. Blood flow calculations 
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Since the labeled microspheres were quickly injected into the left 
ventricle, they were rapidly mixed with the blood and were distributed 
proportionally to blood flow: N/c.o. = R, where c.o. is the cardiac 
output, N is the administered dose of activity, and R is a  constant. 
Since the microspheres trapped in an organ had a count N (counts/minute) 
and the arterial flow to that organ is F (ml/minute), it follows that 
N/F = R. The withdrawal pump, which removes peripheral arterial 
blood at a knm.m rate, represents an "artificial organ." If Np 
(counts/minute) are located in the blood collected by the withdrawal 
pump and if the pump has a withdrawal of Fp (ml/minute) then Np/Fp = N/F. 
After counting the activity ("N") in the portions of the heart, only 
("F") remains unknown and can be easily calculated (Pharmacia, 1975 
and Bartrum et al., 1974), see Figure 3. 
Whole heart blood flow was calculated by taking into account 
the difference in mass of right and left ventricular myocardium and 
thus the difference in blood flow each contributed to the whole. 
12 
Figure 2. Right and left ventricular procurement. 
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Figure 3. Blood flow equation. 
Fp = (ml/min) pump withdrawl rate 
N = (counts/min) of micropheres trapped 
Np = (counts/min) of blood collected by 
F = (ml/min) of arterial blood flow to 
in organ 
withdrawal pump 
organ 
�-
N --
F 
p 
F -
F 
FN 
p 
N
P 
I-' 
V1 
Results 
Renal Blood Flow 
The kidneys which were removed from the rats were used to ascertain 
complete mixing and equal dispersion of microspheres in the blood as it 
was ejected from the left ventricle. The blood flow from both right 
and left kidneys was calculated (ml/min/gm) from all four groups 
and compared (Table 1). The results demonstrated no significant 
difference in microsphere trapping by the two kidneys (P >0.05). This 
served as confirmation of proportional bilateral distribution of 
microspheres in the systemic circulation. 
Right and Left Ventricular Blood Flow 
Ventricular blood flow was calculated as ml/min/gm of tissue. Figure 
4 compares right and left ventricular blood flow for the four different 
treatment groups. All the right and left ventricular blood flows were 
compared to see if blood flow was increased in one ventricle over the 
other and no significance (P > 0.05) was found between them (Table 2). 
Differences in right and left ventricular blood flow also were found to 
be not significant (P > 0.05) as far as any interaction taking place 
between right or left and any one of the treatments (Table 2). 
Whole Heart Blood Flow 
Blood flow in whole heart was calculated as ml/min/gm for all four 
Table 2. Analysis of variance comparing the mean blood flow of the right and left kidneys of the 
four groups. NS (p>.05), 
Sum of 
Source DF* Squares Mean Square Type IV SS** F-Value PR> F 
Side*** 1 -- -- 0.02 0.01 0.9117 
Error 29 36.99 1.28 -- -- --
*DF = Degrees of Freedom 
**SS = Sum of Squares 
***Side = Right and Left Kidneys 
I-' 
--J 
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Figure 4. Effect of estrogen on biood flow in right and left 
ventricles in the four treatment groups. (Each bar 
represents group mean± SE). 
Gl 
= ovariectomized oil group 
G
2 
= normal group 
G
3 
= ovariectomized 4.0 µg estrogen group 
G
4 
= ovariectomized 40.0 µg estrogen group 

Table 3. Analysis of variance comparing the mean blood flow of right and left ventricular 
myocardium (and if effected by the treatment) of the four groups. Both are 
NS(P>.05) 
Source DF* 
Side*** 1 
Side and 
3 Treatment 
Error 28 
*DF = Degrees of Freedom 
*lfSS = Sum of Squares 
Sum Of 
Squares 
--
--
31.4 
***Side = Right and Left Ventricles 
Mean Square Type IV SS** F-Value PR > F 
-- o.41 0.37 0.5493 
-- 1.22 0.36 0.7813 
1.12 -- -- --
I\) 
0 
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Figure 5. Effect of estrogen on blood flow in whole hearts (right plus 
left ventricle) in the four treatment groups. (Ea.ch bar 
represents group mean± SE). 
G
l 
= ovariectomized oil group 
G
2 
= normal group 
G
3 
= ovariectomized 4.0 µg estrogen group 
G
4 
= ovariectomized 40.0 µg estrogen group 
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groups and shown in Figure 5. It is obvious that the greatest mean 
blood flow is seen in G4 (the 40.0 µg group), followed by G2 (normals), 
G3 (
4.0 µg) and G1 (oil). Table 3 shows by analysis of variance 
that the mean blood flow in whole heart in the four groups is 
significantly different (P < 0.01). 
Results of whole heart blood flow are shown in Table 4. The mean 
blood blow of G4 was 131% greater than that of G1 (P < 0.01). However, 
the blood flow rates of G1 
and G3 are not significantly different. 
The mean flow rate of G4 is greater than that of G3 (P < 0.01). 
Estrogen appears to increase blood flow in G
2 
by 65% over G
1 
when 
compared but the difference is not significant (P > 0.05). The blood 
flow means of G2 are higher than that of G3 when compared but this was 
not a significant difference. G4 also has a larger mean blood flow 
than G2 but once more the difference is not significant. 
In summary, G4 had the greater blood flow rates among the four 
groups in the study. It also can be infered from these data that the 
blood flow rates among the groups are proportionally increased as the 
dosage of estrogen administered is also increased (rxy = 0.82). 
Table 4. Analysis of variance comparing the mean blood flow of whole hearts of the four groups. 
Significant (P<.01). 
Sum of 
Source DF* Squares Mean Square Type IV SS** F-Value PR> F 
Treatment 3 -- -- 18.99 6.21 0.006 
Error 14 14.26 1.02 -- -- --
*DF  Degrees of Freedom 
**SS = Sum of Squares 
I\) 
+ 
Table 5, Group Comparisons and Significance Levels of Whole Heart Myocardial Blood 
Flow. 
Difference and Whole Heart % Increase 
Groups Compared Significance Blood Flow In Blood Flow 
(ml/min/gm) 
Group 1 - Group 2 
difference 1.22 65% 
significance NS* NS* 
Group 1 - Group 3 difference .108 5,7% 
significance NS* NS* 
Group 1 - Group 4 
difference 2.46 131% 
significance <.01 <.01 
Group 2 - Group 3 
difference l.ll 56% 
significance NS* NS* 
Group 2 - Group 4 
difference 1.24 40% 
significance NS* NS* 
Group 3 - Group 4 
difference 2.35 lll% 
significance <,01 <.01 
*NS indicates that P>.05 as analyzed by Duncan's multiple range test 
I\) 
V1 
Discussion 
This study was devised to determine whether or not estrogen effects 
blood flow in ventricular myocardial tissue by either decreasing or 
increasing it. Rather than the more complicated method of quantitating 
this by injection of microspheres via retrograde cannulation (McDevitt 
and Nies, 1976) which may result in aortic ejection blockage and 
possible aortic damage, the method of Rakusan and Blahit.ka (1974) was 
used, which employs injection of microspheres directly into the left 
ventricle via cardiac puncture. The data of the experiment indicate 
that estrogen does effect and can increase blood flow to the ventricular 
myocardium of the rat, especially at the 40.0 wg dosage. This is 
supported by the significant differences found in the blood flow 
(ml/min/gm) means between the 40.0 wg estrogen-injected castrates and 
the oil-injected castrates and also the 4.0 wg estrogen-injected 
castrates and the 40.0 wg estrogen-injected castrates in the study. 
As far as estrogen effecting blood flow differently in the right 
or left ventricle, no significant difference was found either related 
or unrelated to the treatment of the groups. 
The discrepancy in mean blood flow between the 4.0 wg group and 
the normal rats may have resulted from the level chosen as the normal 
physiological replacement dosage of estrogen. One would expect that 
the normal physiological replacement group, the 4.0 wg group, would 
position its blood flow closer to the mean of the normal group. This 
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dosage was determined to be the normal replacement amount by McPherson 
et al. (1974) and Eldridge et al. (1974) for younger and smaller rats 
(250 gm). In the present study at the time of sacrifice, however, the 
rats were older and weighed between 250 - 350gm. Thus, it would take a 
greater amount of hormone since the hormone would be diluted by a greater 
mass of tissue So in older rats the replacement dosage lies, most 
likely, slightly above 4.0 wg of estrogen. 
The 40.0 wg group results contradict earlier statements made by 
Jaffe- (1977) that estrogen treatment diminishes coronary blood flow 
and increases coronary smooth muscle tone. This statement was made 
before any attempt had been made to study the effects of estrogen on 
the coronary arteries directly. The present study supports Sullivan 
(1974), Brown et al. (1974) and Silva De Sa' and Meirelles (1977) 
with their conclusion ths.t estrogen is a vasodialator in various-vascular 
beds. 
These findings may be the mechanism by which estrogen provides 
protection to premenopausal women against myocardial infarction 
(Rigano et al., 1963 and Stamler, 1967). This also may account for 
the protection given to men following estrogen therapy after a myocardial 
infarction (Stamler et al., 1963). 
ThA present study i�dicates that estrogen is acting on the vessels 
of the heart, possibly via estrogen target sites in coronary vasculature 
(Stumpf et al., 1977) thus increasing the capacity of the coronary 
microvasculature to perfuse the heart muscle. 
This study reveals 0ne possible mechanism by which estrogen 
acts on the coronary arteries of the ra't heart. Estrogen's past 
history tends to be one of uncertainty and contradictions concerning 
its pharmacological effects on the circulatory system. Estrogen has 
been attributed to producing such side effects as heart disease and 
stroke to name a few. A closer look at different levels of estrogen 
and its effect on the circulatory system should be undertaken to 
evaluate if estrogen can be of better use clinically. Also it should 
be evaluated to see possibly if some of estrogen's so-called side 
effects are induced directly by its effects on blood vessel walls or 
by manifesting its harmful effects by some other mode of action. 
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For example, increased platelet adhesion has been demonstrated in women 
taking pharmacological doses of estrogen in birth control medication. 
This study supports the judgement that estrogen probably provides 
protection from myocardial infarction and alters circulatory problems 
in the heart by way of increasing blood flow if administered within 
physiological ranges. 
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